- Home
- IRMD vs OPK Comparison
IRMD vs OPK Comparison
Compare IRMD & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- OPK
- Stock Information
- Founded
- IRMD 1992
- OPK 2007
- Country
- IRMD United States
- OPK United States
- Employees
- IRMD N/A
- OPK N/A
- Industry
- IRMD Medical/Dental Instruments
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- IRMD Health Care
- OPK Health Care
- Exchange
- IRMD Nasdaq
- OPK Nasdaq
- Market Cap
- IRMD 924.2M
- OPK 1.0B
- IPO Year
- IRMD 2014
- OPK 1995
- Fundamental
- Price
- IRMD $71.99
- OPK $1.35
- Analyst Decision
- IRMD Strong Buy
- OPK Buy
- Analyst Count
- IRMD 1
- OPK 4
- Target Price
- IRMD $72.00
- OPK $2.75
- AVG Volume (30 Days)
- IRMD 47.0K
- OPK 2.0M
- Earning Date
- IRMD 10-30-2025
- OPK 11-06-2025
- Dividend Yield
- IRMD 0.94%
- OPK N/A
- EPS Growth
- IRMD 10.28
- OPK N/A
- EPS
- IRMD 1.61
- OPK N/A
- Revenue
- IRMD $77,635,163.00
- OPK $664,029,000.00
- Revenue This Year
- IRMD $13.76
- OPK N/A
- Revenue Next Year
- IRMD $10.38
- OPK $0.84
- P/E Ratio
- IRMD $44.72
- OPK N/A
- Revenue Growth
- IRMD 11.73
- OPK N/A
- 52 Week Low
- IRMD $44.58
- OPK $1.11
- 52 Week High
- IRMD $74.00
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- IRMD 60.32
- OPK 47.95
- Support Level
- IRMD $70.09
- OPK $1.34
- Resistance Level
- IRMD $74.00
- OPK $1.39
- Average True Range (ATR)
- IRMD 1.57
- OPK 0.04
- MACD
- IRMD -0.43
- OPK -0.00
- Stochastic Oscillator
- IRMD 55.92
- OPK 11.11
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.